Li B, Xi W, Bai Y, Liu X, Zhang Y, Li L, et al. FTO-dependent m6A modification of Plpp3 in circSCMH1-regulated vascular repair and functional recovery following stroke. Nat Commun. 2023;14:489 pubmed publisher

Li B, Chen X, Qiu W, Zhao R, Duan J, Zhang S, et al. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy. Adv Sci (Weinh). 2022;9:e2105451 pubmed publisher

Yu X, Bai Y, Han B, Ju M, Tang T, Shen L, et al. Extracellular vesicle-mediated delivery of circDYM alleviates CUS-induced depressive-like behaviours. J Extracell Vesicles. 2022;11:e12185 pubmed publisher

Zhang R, Fu Y, Cheng M, Ma W, Zheng N, Wang Y, et al. sEVsRVG selectively delivers antiviral siRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV-induced microcephaly in mouse model. Mol Ther. 2021;: pubmed publisher

Kim M, Kim G, Hwang D, Lee M. Delivery of High Mobility Group Box-1 siRNA Using Brain-Targeting Exosomes for Ischemic Stroke Therapy. J Biomed Nanotechnol. 2019;15:2401-2412 pubmed publisher

Kojima R, Bojar D, Rizzi G, Hamri G, El Baba M, Saxena P, et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment. Nat Commun. 2018;9:1305 pubmed publisher

Hung M, Leonard J. Stabilization of exosome-targeting peptides via engineered glycosylation. J Biol Chem. 2015;290:8166-72 pubmed publisher